10X Genomics Stock Forecast - Double Exponential Smoothing

TXG Stock  USD 15.90  0.42  2.71%   
The Double Exponential Smoothing forecasted value of 10X Genomics on the next trading day is expected to be 15.86 with a mean absolute deviation of 0.61 and the sum of the absolute errors of 35.85. 10X Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of 10X Genomics' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
At this time, 10X Genomics' Asset Turnover is most likely to slightly decrease in the upcoming years. . The current Common Stock Shares Outstanding is estimated to decrease to about 85.8 M. The current Net Loss is estimated to decrease to about (156.9 M).
Double exponential smoothing - also known as Holt exponential smoothing is a refinement of the popular simple exponential smoothing model with an additional trending component. Double exponential smoothing model for 10X Genomics works best with periods where there are trends or seasonality.

10X Genomics Double Exponential Smoothing Price Forecast For the 30th of November

Given 90 days horizon, the Double Exponential Smoothing forecasted value of 10X Genomics on the next trading day is expected to be 15.86 with a mean absolute deviation of 0.61, mean absolute percentage error of 0.86, and the sum of the absolute errors of 35.85.
Please note that although there have been many attempts to predict 10X Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that 10X Genomics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

10X Genomics Stock Forecast Pattern

Backtest 10X Genomics10X Genomics Price PredictionBuy or Sell Advice 

10X Genomics Forecasted Value

In the context of forecasting 10X Genomics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. 10X Genomics' downside and upside margins for the forecasting period are 11.27 and 20.45, respectively. We have considered 10X Genomics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
15.90
15.86
Expected Value
20.45
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of 10X Genomics stock data series using in forecasting. Note that when a statistical model is used to represent 10X Genomics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors 0.0549
MADMean absolute deviation0.6076
MAPEMean absolute percentage error0.0348
SAESum of the absolute errors35.8487
When 10X Genomics prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any 10X Genomics trend in the prices. So in double exponential smoothing past observations are given exponentially smaller weights as the observations get older. In other words, recent 10X Genomics observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for 10X Genomics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as 10X Genomics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of 10X Genomics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
10.9415.5320.12
Details
Intrinsic
Valuation
LowRealHigh
13.9326.0730.66
Details
17 Analysts
Consensus
LowTargetHigh
54.9060.3366.97
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.35-0.17-0.07
Details

Other Forecasting Options for 10X Genomics

For every potential investor in 10X, whether a beginner or expert, 10X Genomics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. 10X Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in 10X. Basic forecasting techniques help filter out the noise by identifying 10X Genomics' price trends.

10X Genomics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 10X Genomics stock to make a market-neutral strategy. Peer analysis of 10X Genomics could also be used in its relative valuation, which is a method of valuing 10X Genomics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

10X Genomics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of 10X Genomics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of 10X Genomics' current price.

10X Genomics Market Strength Events

Market strength indicators help investors to evaluate how 10X Genomics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading 10X Genomics shares will generate the highest return on investment. By undertsting and applying 10X Genomics stock market strength indicators, traders can identify 10X Genomics entry and exit signals to maximize returns.

10X Genomics Risk Indicators

The analysis of 10X Genomics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in 10X Genomics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting 10x stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

When determining whether 10X Genomics is a strong investment it is important to analyze 10X Genomics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact 10X Genomics' future performance. For an informed investment choice regarding 10X Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of 10X Genomics to cross-verify your projections.
For more detail on how to invest in 10X Stock please use our How to Invest in 10X Genomics guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 10X Genomics. If investors know 10X will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 10X Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.52)
Revenue Per Share
5.261
Quarterly Revenue Growth
(0.01)
Return On Assets
(0.11)
Return On Equity
(0.25)
The market value of 10X Genomics is measured differently than its book value, which is the value of 10X that is recorded on the company's balance sheet. Investors also form their own opinion of 10X Genomics' value that differs from its market value or its book value, called intrinsic value, which is 10X Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 10X Genomics' market value can be influenced by many factors that don't directly affect 10X Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 10X Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if 10X Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 10X Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.